LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Telecommunications
• Non-Profit & Charity
• Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

lesions, patients, response, tvec, ppr, tumor, injected, uninjected, treatment, melanoma, months, responses, visceral, article, treated, progression, size, fig, analysis, phase, study, baseline, weeks, supplementary, pubmed, electronic, nonvisceral, systemic, time, durable, appendix, google, scholar, amgen, area, lesion, median, gmcsf, evaluable, due, usa, optim, trial, individual, patient, cancer, oncolytic, immunotherapies, cas, patterns,

Topics {✒️}

granulocyte-macrophage colony-stimulating factor-encoding f-fdg pet/ct interpretation anti-cytotoxic t-lymphocyte antigen-4 anti-tumour properties herpes simplex virus stage iiib–iv melanoma generation oncolytic herpesvirus immune-mediated tumor responses positron emission tomography/ct article download pdf lesion-level response analyses anti-pd-1 based immunotherapy enhance t-vec activity immune-related response criteria oncolytic immunotherapy designed tumor-derived antigens institutional review boards receive intralesional t-vec recurrent stage iiib cell responses vertical axis depicts mark shilkrut md clinical trial design received t-vec treatment merrick ross md phase iii study privacy choices/manage cookies lesion-level response analysis lisa chen phd t-vec-treated patients t-vec treated patients 48 t-vec-treated patients t-vec-treated patient phase ii study thomas amatruda md receiving t-vec full access gm-csf arm assigned body-site area immune stimulating distant immunity induced durable tumor remission eddy hsueh md frances collichio md surgical oncology aims residual pigmented areas unresectable metastatic melanoma durable response rate distinguishing true progression mohammed milhem md

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
         description:Talimogene laherparepvec (T-VEC) is an oncolytic immunotherapy designed to induce tumor regression of injected lesions through direct lytic effects, and of uninjected lesions through induction of systemic antitumor immunity. In this study, we describe the patterns and time course of response to T-VEC from the phase III OPTiM trial of 436 patients with unresected stages IIIB–IV melanoma. Lesion-level response analyses were performed based on the type of lesion (injected or uninjected cutaneous, subcutaneous, or nodal lesions; or visceral lesions [uninjected]), and the best percentage change from baseline of the sum of products of the longest diameters was calculated. Patients randomized to T-VEC (n = 295) who experienced a durable response (continuous partial or complete response for ≥6 months) were evaluated for progression prior to response (PPR), defined as the appearance of a new lesion or >25 % increase in total baseline tumor area. T-VEC resulted in a decrease in size by ≥50 % in 64 % of injected lesions (N = 2116), 34 % of uninjected non-visceral lesions (N = 981), and 15 % of visceral lesions (N = 177). Complete resolution of lesions occurred in 47 % of injected lesions, 22 % of uninjected non-visceral lesions, and 9 % of visceral lesions. Of 48 patients with durable responses, 23 (48 %) experienced PPR, including 14 who developed new lesions only. No difference in overall survival was observed, and median duration of response was not reached in patients with PPR versus those without PPR. Responses in uninjected lesions provide validation of T-VEC-induced systemic immunotherapeutic effects against melanoma. PPR did not negatively impact the clinical effectiveness of T-VEC.
         datePublished:2016-06-24T00:00:00Z
         dateModified:2016-06-24T00:00:00Z
         pageStart:4169
         pageEnd:4177
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1245/s10434-016-5286-0
         keywords:
            Ipilimumab
            Overall Response Rate
            Durable Response
            Oncolytic Virus
            Visceral Lesion
            Surgical Oncology
            Oncology
            Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig5_HTML.jpg
         isPartOf:
            name:Annals of Surgical Oncology
            issn:
               1534-4681
               1068-9265
            volumeNumber:23
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Robert H. I. Andtbacka
               affiliation:
                     name:University of Utah
                     address:
                        name:Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Merrick Ross
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Igor Puzanov
               affiliation:
                     name:Vanderbilt University Medical Center
                     address:
                        name:Vanderbilt University Medical Center, Nashville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mohammed Milhem
               affiliation:
                     name:University of Iowa Hospitals and Clinics
                     address:
                        name:University of Iowa Hospitals and Clinics, Iowa City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frances Collichio
               affiliation:
                     name:University of North Carolina
                     address:
                        name:University of North Carolina, Chapel Hill, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Keith A. Delman
               affiliation:
                     name:Emory University
                     address:
                        name:Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Amatruda
               affiliation:
                     name:Minnesota Oncology
                     address:
                        name:Minnesota Oncology, Fridley, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jonathan S. Zager
               affiliation:
                     name:Moffitt Cancer Center
                     address:
                        name:Moffitt Cancer Center, Tampa, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lee Cranmer
               affiliation:
                     name:University of Washington School of Medicine
                     address:
                        name:University of Washington School of Medicine, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eddy Hsueh
               affiliation:
                     name:Saint Louis University Cancer Center
                     address:
                        name:Saint Louis University Cancer Center, St Louis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa Chen
               affiliation:
                     name:Amgen Inc.
                     address:
                        name:Amgen Inc., Thousand Oaks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark Shilkrut
               affiliation:
                     name:Amgen Inc.
                     address:
                        name:Amgen Inc., Thousand Oaks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Howard L. Kaufman
               affiliation:
                     name:Rutgers Cancer Institute of New Jersey
                     address:
                        name:Rutgers Cancer Institute of New Jersey, Rutgers, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
      description:Talimogene laherparepvec (T-VEC) is an oncolytic immunotherapy designed to induce tumor regression of injected lesions through direct lytic effects, and of uninjected lesions through induction of systemic antitumor immunity. In this study, we describe the patterns and time course of response to T-VEC from the phase III OPTiM trial of 436 patients with unresected stages IIIB–IV melanoma. Lesion-level response analyses were performed based on the type of lesion (injected or uninjected cutaneous, subcutaneous, or nodal lesions; or visceral lesions [uninjected]), and the best percentage change from baseline of the sum of products of the longest diameters was calculated. Patients randomized to T-VEC (n = 295) who experienced a durable response (continuous partial or complete response for ≥6 months) were evaluated for progression prior to response (PPR), defined as the appearance of a new lesion or >25 % increase in total baseline tumor area. T-VEC resulted in a decrease in size by ≥50 % in 64 % of injected lesions (N = 2116), 34 % of uninjected non-visceral lesions (N = 981), and 15 % of visceral lesions (N = 177). Complete resolution of lesions occurred in 47 % of injected lesions, 22 % of uninjected non-visceral lesions, and 9 % of visceral lesions. Of 48 patients with durable responses, 23 (48 %) experienced PPR, including 14 who developed new lesions only. No difference in overall survival was observed, and median duration of response was not reached in patients with PPR versus those without PPR. Responses in uninjected lesions provide validation of T-VEC-induced systemic immunotherapeutic effects against melanoma. PPR did not negatively impact the clinical effectiveness of T-VEC.
      datePublished:2016-06-24T00:00:00Z
      dateModified:2016-06-24T00:00:00Z
      pageStart:4169
      pageEnd:4177
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1245/s10434-016-5286-0
      keywords:
         Ipilimumab
         Overall Response Rate
         Durable Response
         Oncolytic Virus
         Visceral Lesion
         Surgical Oncology
         Oncology
         Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_Fig5_HTML.jpg
      isPartOf:
         name:Annals of Surgical Oncology
         issn:
            1534-4681
            1068-9265
         volumeNumber:23
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Robert H. I. Andtbacka
            affiliation:
                  name:University of Utah
                  address:
                     name:Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Merrick Ross
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Igor Puzanov
            affiliation:
                  name:Vanderbilt University Medical Center
                  address:
                     name:Vanderbilt University Medical Center, Nashville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mohammed Milhem
            affiliation:
                  name:University of Iowa Hospitals and Clinics
                  address:
                     name:University of Iowa Hospitals and Clinics, Iowa City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frances Collichio
            affiliation:
                  name:University of North Carolina
                  address:
                     name:University of North Carolina, Chapel Hill, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Keith A. Delman
            affiliation:
                  name:Emory University
                  address:
                     name:Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Amatruda
            affiliation:
                  name:Minnesota Oncology
                  address:
                     name:Minnesota Oncology, Fridley, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jonathan S. Zager
            affiliation:
                  name:Moffitt Cancer Center
                  address:
                     name:Moffitt Cancer Center, Tampa, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lee Cranmer
            affiliation:
                  name:University of Washington School of Medicine
                  address:
                     name:University of Washington School of Medicine, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eddy Hsueh
            affiliation:
                  name:Saint Louis University Cancer Center
                  address:
                     name:Saint Louis University Cancer Center, St Louis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa Chen
            affiliation:
                  name:Amgen Inc.
                  address:
                     name:Amgen Inc., Thousand Oaks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark Shilkrut
            affiliation:
                  name:Amgen Inc.
                  address:
                     name:Amgen Inc., Thousand Oaks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Howard L. Kaufman
            affiliation:
                  name:Rutgers Cancer Institute of New Jersey
                  address:
                     name:Rutgers Cancer Institute of New Jersey, Rutgers, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Annals of Surgical Oncology
      issn:
         1534-4681
         1068-9265
      volumeNumber:23
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Utah
      address:
         name:Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Vanderbilt University Medical Center
      address:
         name:Vanderbilt University Medical Center, Nashville, USA
         type:PostalAddress
      name:University of Iowa Hospitals and Clinics
      address:
         name:University of Iowa Hospitals and Clinics, Iowa City, USA
         type:PostalAddress
      name:University of North Carolina
      address:
         name:University of North Carolina, Chapel Hill, USA
         type:PostalAddress
      name:Emory University
      address:
         name:Emory University, Atlanta, USA
         type:PostalAddress
      name:Minnesota Oncology
      address:
         name:Minnesota Oncology, Fridley, USA
         type:PostalAddress
      name:Moffitt Cancer Center
      address:
         name:Moffitt Cancer Center, Tampa, USA
         type:PostalAddress
      name:University of Washington School of Medicine
      address:
         name:University of Washington School of Medicine, Seattle, USA
         type:PostalAddress
      name:Saint Louis University Cancer Center
      address:
         name:Saint Louis University Cancer Center, St Louis, USA
         type:PostalAddress
      name:Amgen Inc.
      address:
         name:Amgen Inc., Thousand Oaks, USA
         type:PostalAddress
      name:Amgen Inc.
      address:
         name:Amgen Inc., Thousand Oaks, USA
         type:PostalAddress
      name:Rutgers Cancer Institute of New Jersey
      address:
         name:Rutgers Cancer Institute of New Jersey, Rutgers, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Robert H. I. Andtbacka
      affiliation:
            name:University of Utah
            address:
               name:Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Merrick Ross
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Igor Puzanov
      affiliation:
            name:Vanderbilt University Medical Center
            address:
               name:Vanderbilt University Medical Center, Nashville, USA
               type:PostalAddress
            type:Organization
      name:Mohammed Milhem
      affiliation:
            name:University of Iowa Hospitals and Clinics
            address:
               name:University of Iowa Hospitals and Clinics, Iowa City, USA
               type:PostalAddress
            type:Organization
      name:Frances Collichio
      affiliation:
            name:University of North Carolina
            address:
               name:University of North Carolina, Chapel Hill, USA
               type:PostalAddress
            type:Organization
      name:Keith A. Delman
      affiliation:
            name:Emory University
            address:
               name:Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Thomas Amatruda
      affiliation:
            name:Minnesota Oncology
            address:
               name:Minnesota Oncology, Fridley, USA
               type:PostalAddress
            type:Organization
      name:Jonathan S. Zager
      affiliation:
            name:Moffitt Cancer Center
            address:
               name:Moffitt Cancer Center, Tampa, USA
               type:PostalAddress
            type:Organization
      name:Lee Cranmer
      affiliation:
            name:University of Washington School of Medicine
            address:
               name:University of Washington School of Medicine, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Eddy Hsueh
      affiliation:
            name:Saint Louis University Cancer Center
            address:
               name:Saint Louis University Cancer Center, St Louis, USA
               type:PostalAddress
            type:Organization
      name:Lisa Chen
      affiliation:
            name:Amgen Inc.
            address:
               name:Amgen Inc., Thousand Oaks, USA
               type:PostalAddress
            type:Organization
      name:Mark Shilkrut
      affiliation:
            name:Amgen Inc.
            address:
               name:Amgen Inc., Thousand Oaks, USA
               type:PostalAddress
            type:Organization
      name:Howard L. Kaufman
      affiliation:
            name:Rutgers Cancer Institute of New Jersey
            address:
               name:Rutgers Cancer Institute of New Jersey, Rutgers, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
      name:University of Texas MD Anderson Cancer Center, Houston, USA
      name:Vanderbilt University Medical Center, Nashville, USA
      name:University of Iowa Hospitals and Clinics, Iowa City, USA
      name:University of North Carolina, Chapel Hill, USA
      name:Emory University, Atlanta, USA
      name:Minnesota Oncology, Fridley, USA
      name:Moffitt Cancer Center, Tampa, USA
      name:University of Washington School of Medicine, Seattle, USA
      name:Saint Louis University Cancer Center, St Louis, USA
      name:Amgen Inc., Thousand Oaks, USA
      name:Amgen Inc., Thousand Oaks, USA
      name:Rutgers Cancer Institute of New Jersey, Rutgers, USA

External Links {🔗}(94)

• What are the total earnings of https://www.springernature.com/gp/authors?
• How much does https://link.springernature.com/home/ rake in every month?
• Income figures for https://order.springer.com/public/cart
• Revenue of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• Learn how profitable https://mc.manuscriptcentral.com/aso is on a monthly basis
• What's the monthly income of https://beta.springernature.com/pre-submission?journalId=10434?
• How much revenue does https://doi.org/10.1038%2Fsj.gt.3301885 generate?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12595888 generate monthly?
• How profitable is http://scholar.google.com/scholar_lookup?&title=ICP34.5%20deleted%20herpes%20simplex%20virus%20with%20enhanced%20oncolytic%2C%20immune%20stimulating%2C%20and%20anti-tumour%20properties&journal=Gene%20Therapy&doi=10.1038%2Fsj.gt.3301885&volume=10&issue=4&pages=292-303&publication_year=2003&author=Liu%2CBL&author=Robinson%2CM&author=Han%2CZQ?
• How much income does https://doi.org/10.1200%2FJCO.2009.24.3675 have?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19884534 make?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20clinical%20trial%20of%20a%20granulocyte-macrophage%20colony-stimulating%20factor-encoding%2C%20second-generation%20oncolytic%20herpesvirus%20in%20patients%20with%20unresectable%20metastatic%20melanoma&journal=J%20Clin%20Oncol.&doi=10.1200%2FJCO.2009.24.3675&volume=27&issue=34&pages=5763-5771&publication_year=2009&author=Senzer%2CNN&author=Kaufman%2CHL&author=Amatruda%2CT make?
• How much money does https://doi.org/10.1200%2FJCO.2014.58.3377 make?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26014293 generate?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Talimogene%20Laherparepvec%20Improves%20Durable%20Response%20Rate%20in%20Patients%20With%20Advanced%20Melanoma&journal=J%20Clin%20Oncol.&doi=10.1200%2FJCO.2014.58.3377&volume=33&issue=25&pages=2780-2788&publication_year=2015&author=Andtbacka%2CRHI&author=Kaufman%2CHL&author=Collichio%2CF?
• What is the monthly revenue of https://doi.org/10.1158%2F1078-0432.CCR-06-0759?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17121894 generate?
• How much income is http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20study%20of%20OncoVEXGM-CSF%2C%20a%20second-generation%20oncolytic%20herpes%20simplex%20virus%20expressing%20granulocyte%20macrophage%20colony-stimulating%20factor&journal=Clin%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-06-0759&volume=12&issue=22&pages=6737-6747&publication_year=2006&author=Hu%2CJC&author=Coffin%2CRS&author=Davis%2CCJ earning monthly?
• What's the profit of https://doi.org/10.1200%2FJCO.2013.53.0105?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24590637
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811023?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Survival%2C%20durable%20tumor%20remission%2C%20and%20long-term%20safety%20in%20patients%20with%20advanced%20melanoma%20receiving%20nivolumab&journal=J%20Clin%20Oncol.&doi=10.1200%2FJCO.2013.53.0105&volume=32&issue=10&pages=1020-1030&publication_year=2014&author=Topalian%2CSL&author=Sznol%2CM&author=McDermott%2CDF
• How much does https://doi.org/10.1002%2F1097-0142%2819810101%2947%3A1%3C207%3A%3AAID-CNCR2820470134%3E3.0.CO%3B2-6 earn?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7459811?
• How much money does http://scholar.google.com/scholar_lookup?&title=Reporting%20results%20of%20cancer%20treatment&journal=Cancer&doi=10.1002%2F1097-0142%2819810101%2947%3A1%3C207%3A%3AAID-CNCR2820470134%3E3.0.CO%3B2-6&volume=47&issue=1&pages=207-214&publication_year=1981&author=Miller%2CAB&author=Hoogstraten%2CB&author=Staquet%2CM&author=Winkler%2CA make?
• Explore the financials of https://doi.org/10.1245%2Fs10434-009-0809-6
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19915919 rake in every month?
• How much does http://scholar.google.com/scholar_lookup?&title=Local%20and%20distant%20immunity%20induced%20by%20intralesional%20vaccination%20with%20an%20oncolytic%20herpes%20virus%20encoding%20GM-CSF%20in%20patients%20with%20stage%20IIIc%20and%20IV%20melanoma&journal=Ann%20Surg%20Oncol.&doi=10.1245%2Fs10434-009-0809-6&volume=17&issue=3&pages=718-730&publication_year=2010&author=Kaufman%2CHL&author=Kim%2CDW&author=DeRaffele%2CG&author=Mitcham%2CJ&author=Coffin%2CRS&author=Kim-Schulze%2CS generate monthly?
• How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-09-1624 produce monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19934295's revenue stream
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Guidelines%20for%20the%20evaluation%20of%20immune%20therapy%20activity%20in%20solid%20tumors%3A%20immune-related%20response%20criteria&journal=Clin%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-09-1624&volume=15&issue=23&pages=7412-7420&publication_year=2009&author=Wolchok%2CJD&author=Hoos%2CA&author=O%E2%80%99Day%2CS?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24971417's gross income?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Delayed%20response%20in%20ipilimumab%20therapy&journal=J%20Community%20Support%20Oncol.&volume=12&issue=3&pages=109-110&publication_year=2014&author=Megahed%2CA&author=Faulhaber%2CP&author=Phillips%2CT&author=Koon%2CH?
• How much does https://doi.org/10.1200%2FJCO.2015.61.6870 gross monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26261262 gross monthly?
• How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622096 generate?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Pseudoprogression%20and%20immune-related%20response%20in%20solid%20tumors&journal=J%20Clin%20Oncol.&doi=10.1200%2FJCO.2015.61.6870&volume=33&issue=31&pages=3541-3543&publication_year=2015&author=Chiou%2CVL&author=Burotto%2CM?
• How much money does https://doi.org/10.1200%2FJCO.2005.06.205 generate?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16087944 make?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473965?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Autoimmunity%20correlates%20with%20tumor%20regression%20in%20patients%20with%20metastatic%20melanoma%20treated%20with%20anti-cytotoxic%20T-lymphocyte%20antigen-4&journal=J%20Clin%20Oncol.&doi=10.1200%2FJCO.2005.06.205&volume=23&issue=25&pages=6043-6053&publication_year=2005&author=Attia%2CP&author=Phan%2CGQ&author=Maker%2CAV?
• How much profit does https://doi.org/10.1097%2FRLU.0b013e31828da691 generate?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23640225?
• How much money does http://scholar.google.com/scholar_lookup?&title=Ipilimumab-induced%20immunomediated%20adverse%20events%3A%20possible%20pitfalls%20in%20%2818%29F-FDG%20PET%2FCT%20interpretation&journal=Clin%20Nucl%20Med&doi=10.1097%2FRLU.0b013e31828da691&volume=39&issue=5&pages=472-474&publication_year=2014&author=Gilardi%2CL&author=Colandrea%2CM&author=Vassallo%2CS&author=Travaini%2CLL&author=Paganelli%2CG make?
• How much does https://doi.org/10.1016%2Fj.ejca.2008.10.026 gross monthly?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer.&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&issue=2&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ produce monthly?
• What's the monthly income of https://citation-needed.springer.com/v2/references/10.1245/s10434-016-5286-0?format=refman&flavour=references?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20H.%20I.%20Andtbacka?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20H.%20I.%20Andtbacka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Merrick%20Ross earn?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Merrick%20Ross%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Igor%20Puzanov's revenue stream
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Igor%20Puzanov%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mohammed%20Milhem makes per month
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mohammed%20Milhem%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Frances%20Collichio make?
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Frances%20Collichio%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Keith%20A.%20Delman
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Keith%20A.%20Delman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Thomas%20Amatruda?
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Thomas%20Amatruda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jonathan%20S.%20Zager income
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jonathan%20S.%20Zager%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lee%20Cranmer's revenue stream
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lee%20Cranmer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eddy%20Hsueh?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eddy%20Hsueh%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lisa%20Chen making per month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lisa%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20Shilkrut
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20Shilkrut%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Howard%20L.%20Kaufman have?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Howard%20L.%20Kaufman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Monthly income for https://static-content.springer.com/esm/art%3A10.1245%2Fs10434-016-5286-0/MediaObjects/10434_2016_5286_MOESM1_ESM.docx
• How much profit is http://creativecommons.org/licenses/by/4.0/ making per month?
• Learn about the earnings of https://s100.copyright.com/AppDispatchServlet?title=Patterns%20of%20Clinical%20Response%20with%20Talimogene%20Laherparepvec%20%28T-VEC%29%20in%20Patients%20with%20Melanoma%20Treated%20in%20the%20OPTiM%20Phase%20III%20Clinical%20Trial&author=Robert%20H.%20I.%20Andtbacka%20MD%2C%20CM%2C%20FACS%20FRCSC%20et%20al&contentID=10.1245%2Fs10434-016-5286-0©right=The%20Author%28s%29&publication=1068-9265&publicationDate=2016-06-24&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
• How much does https://crossmark.crossref.org/dialog/?doi=10.1245/s10434-016-5286-0 earn?
• What's https://citation-needed.springer.com/v2/references/10.1245/s10434-016-5286-0?format=refman&flavour=citation's gross income?
• How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral gross monthly?
• How much profit is https://www.springernature.com/gp/products making per month?
• Explore the financials of https://www.springernature.com/gp/librarians
• https://www.springernature.com/gp/societies's total income per month
• Financial intake of https://www.springernature.com/gp/partners
• https://www.springer.com/ income
• https://www.nature.com/ income
• How much does https://www.biomedcentral.com/ rake in every month?
• What's the income generated by https://www.palgrave.com/ each month?
• Discover the revenue of https://www.apress.com/
• How much does https://www.springernature.com/gp/legal/ccpa bring in each month?
• How much revenue does https://www.springernature.com/gp/info/accessibility generate?
• Earnings of https://support.springernature.com/en/support/home
• Learn how profitable https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations is on a monthly basis
• How much does https://www.springernature.com/ rake in every month?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref